Verva Pharmaceuticals vervapharma.com


Public lists: Pharma Startups (4732)

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

Company (Alive / Active)

Phone:

Fax:

199 Moorabool Street
Level 4
VIC 3220
Australia

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Verva Pharmaceuticals $2.4M Oct 27, 2011
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Verva Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Xanthus Pharmaceuticals

Cambridge, Massachusetts, United States
AcquiredXanthus Pharmaceuticals, Inc. is developing a portfolio of novel, clinical-stage, small-molecule therapeutic candidates through a management team whose accomplished track record encompasses all aspects of drug development, from discovery through regulatory approval and commercialisation. The Company is applying its expertise to advance its current pipeline to address significant unmet medical need in oncology and autoimmune diseases. Xanthus is headquartered in Cambridge, Massachusetts with an a...Show allLogin to see details

Allon Therapeutics

Vancouver, British Columbia, Canada
AcquiredAllon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizophrenia and cognitive impairment.The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" (Neuroprotection CompanyTM) and based in Vancouver.Login to see details
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Insulin sensitisers and methods of treatment May 31, 2013 Sep 27, 2016 Patent
Insulin sensitisers and methods of treatment Jan 25, 2008 Jun 04, 2013 Patent
Metabolism-modulating agents and uses therefor Aug 16, 2005 Mar 29, 2011 Patent
Differentiation modulating agents and uses therefor Oct 07, 2013 Application
Method of improving liver function Mar 15, 2013 Application